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sresentation with acute type B aortic dissection (B-AD) in
the setting of malperfusion is associated with a high risk
or major morbidity due to end-organ ischemia. This presen-
ation has traditionally been considered an indication for op-
ration where the entry tear is resected, and branch vessel
erfusion is subsequently restored either as a result of the
ortic repair or by direct revascularization of the peripheral
rterial bed.
There are two predominant mechanisms by which mal-
erfusion can occur, and these have previously been defined
y our group.1,2 In static obstruction, the dissection flap en-
ers the branch vessel lumenwithout an adequate reentry tear
or a diminutive reentry tear) within the course of that artery.
he compromised true lumen of that artery then becomes
he sole source of inflow into that end organ. In contrast,
n dynamic obstruction, the mobile aortic dissection flap
ntermittently covers the orifice of the branch vessel dur-
ng the cardiac cycle, thus impeding arterial inflow into
he end organ. Treatment is directed at restoring the in-
egrity of the arterial true lumen in static obstruction and
f the aortic true lumen in dynamic obstruction. Finally,
nd-organ perfusion may be compromised by a combina-
ion of both mechanisms, as well as by miscellaneous
auses including thrombosis or embolism of branches
upplied by either lumen.
Whereas malperfusion has traditionally been an indication
o proceed with early operative repair of the aorta, endovas-
ular approaches have emerged as an alternative to allow
estoration of end-organ perfusion. Two types are discussed
n this report, and each has a different focus. The traditional
ndovascular approach has relied on a percutaneous method
f creating a fenestration in the dissection flap to equalize
ressures and allow flow between the true and false lumina. A
elf-expanding stent (typically 16 to 22 mm in diameter) is
hen placed in the aortic true lumen to maintain its patency
nd thereby allow continued antegrade perfusion of the
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doi:10.1053/j.optechstcvs.2007.10.001ranch vessel. This approach typically resolves the dynamic
ype of obstruction. If static obstruction is identified, self-
xpanding stents are placed within the true lumen of the
ranch vessel, much in the same way typical obstructive ar-
erial lesions are treated. The primary goal of this approach is
o restore end-organ perfusion, without addressing the
athologic aortic problem directly (ie, repair of primary tear
r prevention of false lumen expansion). Although the focus
f this report is type B dissections, we have reported this as an
ffective means to restore end-organ perfusion in type A dis-
ection presenting with malperfusion.
Thoracic endovascular repair (TEVAR) has been increas-
ngly utilized as an alternative to percutaneous fenestration.
ith this approach, the endograft is deployed to cover the
rimary entry tear within the true lumen. As a result, the true
umen then expands, and dynamic branch vessel compro-
ise is ameliorated. By eliminating flow through the pri-
ary entry tear, false lumen flow is significantly reduced,
nd its thrombosis then induced. If then present, static
ranch vessel obstruction is treated with self-expanding
tents as above. In contrast to percutaneous fenestration
nd true lumen stenting, this approach may treat both the
alperfusion component as well as the primary pathologic
ortic problem.
We find that preoperative workup for either approach in-
ludes the need for dynamic computed tomography (CT)
canning from the thoracic inlet to the femoral heads. Key
nformation gleaned from this examination includes identi-
ying whether and by what mechanism branch vessel ob-
truction exists, andwhether an associated aortic aneurysm is
resent. The latter is an important determinant of proceeding
ith TEVAR as opposed to percutaneous fenestration.
e have noted during the intervention, however, that mul-
iple branch vessels may be compromised, when in fact only
ne vascular bed was suggested as being affected on preop-
rative clinical or imaging examination.
There cannot be enough emphasis placed on attention to
reoperative endograft planning, as the durability of TEVAR
epends not only on stability of the proximal landing zone
ut also on the accuracy of the sizing. We have found that 3D
econstructions of CT scans are quite useful both in deter-
ining the suitability of TEVAR as well as in assisting with
izing considerations. This adjunct also aids in determining
he access vessels in TEVAR. For TEVAR (in contrast to per-
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Endovascular therapy for malperfusion 3utaneous fenestration), we have had a liberal policy toward
sing a lumbar drain to reduce intrathecal pressure and po-
entially reduce the dreaded postoperative complication ofnd left in place for 36 to 48 hours postoperatively. Permis-
ive hypertension (keeping the spinal perfusion pressure
ver 80 mm Hg) is also used as an adjunct for the first 48 toaraplegia. These are typically placed before the procedure 72 hours.
Operative Techniques
Thoracic Aortic Endovascular Repair
igure 1 A type B aortic dissection is depicted
etailing the anatomy. Intravascular ultra-
onography (IVUS, catheter not shown) is an
nvaluable aid in treatment of B-AD with
alperfusion. The cross-sectional images of
he aorta and branch vessels correlate to the
mages seen on IVUS. By depicting the rela-
ion of the dissection flap to branch artery
rigins, IVUS demonstrates which branches
re likely to be compromised and by what
echanism. Because of the high frequency of
ulti-organ compromise, branch artery ma-
ometry and arteriography with hand-injec-
ions of contrast (not shown) are performed
o confirm patency and perfusion of renal,
uperior mesenteric, and if indicated, the il-
ac arteries. In this figure, the primary entry
ear is situated in the proximal descending
horacic aorta. The dissection flap distal to
his shows evidence of collapse of the true
umen with dynamic obstruction of the ce-
iac and superior mesenteric arteries. In
hese vessels, the dissection does not extend
nto them but rather occludes them by inter-
ittent obstruction of the flap during the
ardiac cycle. In contrast, the left renal artery
hows evidence of dissectionwithout reentry
n the course of the branch vessel. In this
ranch, there is formation of thrombus in
he left renal artery false lumen, which in
urn causes a static obstruction and renal
alperfusion. F  false lumen; SMA  su-
erior mesenteric artery; T  true lumen.
4 H.J. Patel and D.M. WilliamsFigure 2 Preoperative CT scanning is essential to determine adequacy of the proximal landing zone.We typically extend
coverage up to the left subclavian artery in cases of type B aortic dissection, often noting the need for complete coverage
to obtain a 2-cm landing zone (A). The only commercially available endograft comes in sizes from 26 to 40 mm in
diameter. In determining the correct endograft size, we obtain measurements at the proximal edge of the pathologic
problem and then at 1-cm proximal increments. The selected endograft then has a diameter no more than 10% larger
than the aortic diameter at the landing zone. For (A), a 31-mm graft would be selected. Finally a short (10-15 cm) stent
graft length is commonly utilized in our experience to avoid extensive intercostal artery coverage. Additional anatomic
requirements for TEVAR include the absence of a tapered neck, the presence of a 2-cm proximalmargin, and a relatively
“flat” arch (in contrast to a “Gothic” arch) to allow for suitable apposition of the endograft to the aortic lesser curvature.
Finally, the access vessels are determined. The ideal vessel is straight, not calcified, and of adequate diameter to
accommodate the delivery sheath for the endograft (ie, the right femoral artery in B). We have liberally used intraop-
erative iliac angioplasty to allow for femoral delivery in cases of short discrete iliac stenosis. If these access vessel
requirements are not met, we plan delivery via a conduit placed on the common iliac artery. In our experience, the iliac
arteries of patients with aortic dissection are more often ectatic than stenotic, and the need for adjunctive iliac
angioplasty is reduced compared with the population of patients with degenerative thoracic aneurysms. d  luminal
diameter.
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Endovascular therapy for malperfusion 5igure 3 After IVUS examination as well as
nitial angiography of the arch to determine
reat vessel origin (Fig. 1), the access vessels
re cannulated. The tortuous left iliac artery
n this case serves as the route for percutane-
us placement of a marker pigtail catheter,
sed for both angiography and assistance in
arking the site of deployment. Via an open
xposure of the right femoral artery, the de-
ivery sheath is placed into the terminal aorta
not shown) over a stiff Lunderquist wire.
he wire position is maintained typically in
he ascending aorta throughout the proce-
ure. Note that it is important to ensure true
umen placement of both wires to avoid the
atastrophic complications of false lumen
ndograft deployment or of extension of dis-
ection to a type A. Finally, the endograft is
ituated in the correct site and deployment is
egun. SMA  superior mesenteric artery.
6 H.J. Patel and D.M. WilliamsFigure 4 After endograft deployment, balloon dilation to profile only can be performed at the proximal landing zone
only (not shown). We have been somewhat reluctant to do this for fear of tearing the already inflamed aorta.
Completion aortography demonstrates accurate deployment and elimination of flow via the entry tear. IVUS exami-
nation of the remaining nontreated aorta confirms resolution of dynamic obstruction (A). However, as is shown in this
figure, the left renal artery demonstrates static obstruction and this is confirmed by obtaining pressure gradients from
the aorta to the renal hilum in the renal artery true lumen (B). F false lumen; SMA superior mesenteric artery; T
true lumen.
Endovascular therapy for malperfusion 7Figure 5 In the event of angiographically significant stenosis, or a measurement of a 20 mm Hg systolic gradient, the
renal true lumen is stented with a self-expanding stent that is sized 10% more than the diameter of the renal artery.
Completion manometry demonstrates branch vessel patency and adequate antegrade branch vessel flow. F  false
lumen; SMA  superior mesenteric artery; T  true lumen.
8 H.J. Patel and D.M. WilliamsPercutaneous Fenestration and Stenting
Figure 6 This figure again depicts
the aorta after angiography and
IVUS examination. Access for this
procedure is entirely percutaneous.
The entry tear site is confirmed, and
there is evidence of dynamic and
static branch vessel flow. Pressure
measurements are obtained at the
aortic root, and in selected branch
vessels (not shown). When branch
vessel obstruction is present, the
goal is to reperfuse the mesenteric
vessels first, followed by renal and
limb revascularization. R-URosch-
Uchida needle; SMA superiormes-
enteric artery.
Endovascular therapy for malperfusion 9Figure 7 The true lumen is cannulated and a Rosch-Uchida needle (Cook, Bloomington, IN) is then placed from the true
into the false lumen in a perpendicular manner with IVUS monitoring (A). The site of fenestration is at the branch
vessels that are intended for therapy. A wire and subsequently a 5-Fr catheter are then placed into the false lumen (B).
IVUS or small-dose contrast delivery can confirm the false lumen location of the catheter. A 14-mm balloon is then
placed at the puncture hole in the flap (C) and then inflated often without seeing a “waist” to create a fenestration (D).
RU  Rosch-Uchida needle; SMA  superior mesenteric artery.
10 H.J. Patel and D.M. WilliamsFigure 8 Although fenestration can equalize pressures across the dissection flap, self-expanding 16- to 22-mm-diameter
Wallstents (Schneider, Minneapolis, MN) are usually placed to buttress open the aortic true lumen and are typically
placed near the compromised branch vessel (A). These are usually inserted via the already obtained percutaneous
access sheaths and deployed by IVUS guidance. Care is taken to withdraw the guidewire from across the fenestration
tear and re-advance it within the aortic true lumen, so as to deploy the stents exclusively within the aortic true lumen,
rather than straddle the tear from true to false lumen. Neglecting this critical step adds greatly to the complexity of the
procedure. Fenestration and stenting of the aortic true lumen treats the dynamic obstruction of the depictedmesenteric
vessels, but not the static obstruction seen in the depicted left renal artery. In this branch, pressure measurements
confirm a significant (20 mm Hg) systolic gradient requiring additional treatment (B). SMA  superior mesenteric
artery.
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Endovascular therapy for malperfusion 11onclusions
t the University of Michigan Hospital, we have evaluated
05 patients for either type A or B dissection with malperfu-
ion from 1997 to 2007. An additional 33 patients have un-
ergone TEVAR for treatment of acute (true “double-barrel”
issection or its variants of intramural hematoma with or
ithout penetrating ulcer) or chronic dissection since the
nception of our thoracic endovascular program in 1993.3,4
lthough the long-term results of percutaneous fenestration
nd stenting are documented, the results from TEVAR in this
etting remain to be defined. We have found that TEVAR in
atients with acute dissection variants of intramural hema-
oma with or without penetrating ulcer to be particularly
exing with a high incidence of fixation site complications
eg, pseudoaneurysm formation).3 With recognition of these
roblems, we have evolved our technique to avoid balloon-
ng the endograft after deployment particularly in areas of
issected aorta. When the dissection extends proximally to
ear the subclavian artery, we try to land the stent graft prox-
igure 9 Again, the true lumen of the left
enal artery that is compromised by a static
bstruction is cannulated and treated with
self-expanding stent to relieve the ob-
truction. Completion aortorenal manom-
try confirms adequate perfusion. SMA 
uperior mesenteric artery.mally to cover the left subclavian artery. We do this partlyecause we have noted from open surgery that even though
his area may not have a true dissection, it is still quite in-
amed and may potentially serve as a poor proximal fixation
ite. Finally, we believe that, in the setting of infradiaphrag-
atic malperfusion, the benchmark for TEVAR remains per-
utaneous fenestration and stenting with subsequent elective
pen repair if needed for aneurysmal degeneration, given its
nown documented durable results.
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